AbbVie
ABBV
ABBV
1,500 hedge funds and large institutions have $72.7B invested in AbbVie in 2014 Q3 according to their latest regulatory filings, with 105 funds opening new positions, 581 increasing their positions, 588 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,500
Holders Change
+44
Holders Change %
+3.02%
% of All Funds
43.55%
Holding in Top 10
80
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+15.94%
% of All Funds
2.32%
New
105
Increased
581
Reduced
588
Closed
50
Calls
$1.05B
Puts
$449M
Net Calls
+$597M
Net Calls Change
+$482M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.4B |
| 2 |
SC
Sculptor Capital
New York
|
+$882M |
| 3 |
PC
Paulson & Co
New York
|
+$751M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$622M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$560M |
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
-$659M |
| 2 |
D.E. Shaw & Co
New York
|
-$324M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$290M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$211M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$196M |